Skip to content

Effect of L-carnosine versus early intensive behavioural intervention (EIBI) in children with Autism

Effect of L-carnosine versus early intensive behavioural intervention (EIBI) in children with Autism spectrum disorder: A randomized, open label, active controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018568
Enrollment
Unknown
Registered
2019-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder Health Condition 2: F840- Autistic disorder

Interventions

Intervention1: L-Carnosine: L-carnosine group will receive dose of 20 ml to 40 ml/ day (400 to 800 mg/day) oral for one year duration Control Intervention1: Early Intensive Behavioral Intervention (EI

Sponsors

Indian council of Medical Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.All children clinically diagnosed ASD according to DSM 5 2.Children with ASD with age range 2-6 years 3.Parents willing to give informed consent for therapeutic intervention for ASD and to participate in the study

Exclusion criteria

Exclusion criteria: 1.Previous experience with any kind of therapy with significant improvement in clinical symptoms 2.Significant medical or sensory/motor impairments such as a blindness or deafness 3.A traumatic head injury; genetic/neurological condition or disease 4.Significant cognitive impairment 5.Family history of genetic/neurological condition

Design outcomes

Primary

MeasureTime frame
ISAA (Indian Scale for Assessment of Autism ) Timepoint: Baseline, After 3 and 12 months

Secondary

MeasureTime frame
SOFAS (Social and occupational functioning assessment scaleTimepoint: Baseline, After 3 and 12 months

Countries

India

Contacts

Public ContactDr Rajeev Ranjan

All India Institute of Medical Sciences, Patna

rajeevranjan0087@gmail.com9717531800

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026